Cardinal Health (CAH) has been subjected to a series of developments lately. While its stock price fluctuated, underperforming the market on some days, it ended up yielding gains. The company has shown a significant advancement in the market, resulting in a bullish outlook for its Fiscal 2025. Its accumulated short interest also increased by 42.9% in August. Following these, CAH commemorated World Suicide Prevention Day by emphasizing continued focus on youth mental health. The company's Board of Directors reaffirmed the Fiscal non-GAAP EPS Guidance and Long-term targets even amidst the nonrenewal of OptumRx Customer Contracts. The company is also expanding its presence, with recent events including the opening of a distribution center at Greenville, South Carolina. Other key updates are the acquisition of Specialty Networks and its PPS Analytics platform, both significant contributors to urology, rheumatology, gastroenterology, and Cardinal Health's annual research report highlighted a landmark year in biosimilars. Lastly, CAH is said to lose OptumRx contracts, and their stock saw a decline on the back of mixed quarterly results.
Cardinal Health CAH News Analytics from Fri, 03 Nov 2023 07:00:00 GMT to Sun, 15 Sep 2024 03:30:21 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor -3
